Literature DB >> 16036176

Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium.

Hi-Gung Bae1, Christian Drosten, Petra Emmerich, Robert Colebunders, Philippe Hantson, Stefan Pest, Muriel Parent, Herbert Schmitz, Marc-Aurel Warnat, Matthias Niedrig.   

Abstract

BACKGROUND: Yellow fever remains one of the great burdens for public health in the endemic regions in Africa and South America. The under reporting of yellow fever cases in the respective regions and lack of international interest leads to an underestimation of the constant danger in these areas. Non-vaccinated travelers take a high risk without the effective protection of YFV 17D vaccination.
OBJECTIVES: Two YF cases were imported to Europe in the last 4 years. We characterized two yellow fever virus (YFV) isolates from severely infected patients coming back from Africa, Ivory Coast and The Gambia, by genome sequencing and phylogenetic analysis. STUDY
DESIGN: The virus infections in different organs were analyzed with pathological, immunohistological, electronmicroscopical and quantitative real-time PCR methods. RESULTS AND
CONCLUSION: High virus loads in spleen and liver (2.4 x 10 (6) to 3 x 10 (7)GE/mL) demonstrated by real time PCR show massive virus replication leading to extraordinary progression of the disease in these patients. Immunohistological and electronmicroscopical analysis confirms virus particles in liver tissue. In all other organs no virus could be detected. A fast, specific and sensitive virus PCR detection is recommended for diagnostic of acute infections. The further sequence alignments show that the new isolates belong to the type II West African strain with great homology to over 40-year old YF isolates from Senegal and Ghana. The divergence observed was on average 3.3%, ranging from 0.0% to 5.0% in the coding region of Gambia 2001 strain and 2.9 %, ranging from 0.0% to 4.3% in the coding region of the Ivory C 1999 strain. Most mutations (5.0%/4.3%, respectively) occurred in the envelope protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036176     DOI: 10.1016/j.jcv.2004.12.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  24 in total

Review 1.  A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options.

Authors:  Jolyon M Medlock; Kayleigh M Hansford; Francis Schaffner; Veerle Versteirt; Guy Hendrickx; Herve Zeller; Wim Van Bortel
Journal:  Vector Borne Zoonotic Dis       Date:  2012-04-20       Impact factor: 2.133

2.  Detection of yellow fever 17D genome in urine.

Authors:  Cristina Domingo; Sergio Yactayo; Edinam Agbenu; Maurice Demanou; Axel R Schulz; Katjana Daskalow; Matthias Niedrig
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

3.  Genomic and phylogenetic characterization of Brazilian yellow fever virus strains.

Authors:  Marcio R T Nunes; Gustavo Palacios; Jedson F Cardoso; Livia C Martins; Edivaldo C Sousa; Clayton P S de Lima; Daniele B A Medeiros; Nazir Savji; Aaloki Desai; Sueli G Rodrigues; Valeria L Carvalho; W Ian Lipkin; Pedro F C Vasconcelos
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

4.  Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories.

Authors:  Cristina Domingo; Pranav Patel; Jasmin Yillah; Manfred Weidmann; Jairo A Méndez; Emmanuel Rivalyn Nakouné; Matthias Niedrig
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

5.  Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.

Authors:  Justin G Julander; John D Morrey; Lawrence M Blatt; Kristiina Shafer; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-09-22       Impact factor: 5.970

6.  STATEMENT FOR TRAVELLERS AND YELLOW FEVER: An Advisory Committee Statement (ACS) Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  This Statement Was Prepared By P Charlebois
Journal:  Can Commun Dis Rep       Date:  2013-03-05

7.  Statement for Travellers and Yellow Fever: Committee to Advise on Tropical Medicine and Travel.

Authors:  P Charlebois
Journal:  Can Commun Dis Rep       Date:  2010-10-02

Review 8.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

9.  Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.

Authors:  Justin G Julander; Kristiina Shafer; Donald F Smee; John D Morrey; Yousuke Furuta
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

10.  Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa.

Authors:  Nina K Stock; Hewád Laraway; Ousmane Faye; Mawlouth Diallo; Matthias Niedrig; Amadou A Sall
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.